Delivery Order SPE2DB22D1103-SPE2DB24FTEJ5

Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $3.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $27,493.49 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the ROTARIX vaccine oral syringes (1.5mL) with a completion date of March 6, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,689.70 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide ROTARIX vaccine oral syringes. The contract has a completion date of January 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is based in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the ROTARIX vaccine oral syringe 1.5ML. The $5,424.14 award has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
The Defense Logistics Agency has awarded a firm fixed price delivery order worth $7,880.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ROTARIX VACCINE ORAL SYRINGE 1.5ML. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract has a potential value of $13,074.67 and a completion date of January 31, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTARIX vaccine oral syringe 1.5ML. The contract has a potential value of $3,853.43 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not part of a larger contract vehicle. No set-aside designation was used...
The Defense Logistics Agency (DLA) awarded a $36,887.14 firm-fixed price delivery order to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, for the supply of ROTARIX vaccine oral syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the ROTARIX vaccine oral syringe 1.5ml. The contract has a potential value of $16,158.93 and a performance period from January 9, 2024 to January 10, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, valued at up to...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,640,750 units of the ROTARIX vaccine in 10-dose kits. The $2,554.83 order has a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, that serves as the primary...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTEJ5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ROTARIX vaccine oral syringes. The $3,660.63 delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 4/26/24, 11:05 AM